ATE190663T1 - Cd69 - transkriptionsregulierende elemente - Google Patents

Cd69 - transkriptionsregulierende elemente

Info

Publication number
ATE190663T1
ATE190663T1 AT95908618T AT95908618T ATE190663T1 AT E190663 T1 ATE190663 T1 AT E190663T1 AT 95908618 T AT95908618 T AT 95908618T AT 95908618 T AT95908618 T AT 95908618T AT E190663 T1 ATE190663 T1 AT E190663T1
Authority
AT
Austria
Prior art keywords
pct
regulatory elements
date
transcription regulatory
sec
Prior art date
Application number
AT95908618T
Other languages
English (en)
Inventor
Andrew L Feldhaus
Steven F Ziegler
Original Assignee
Targeted Genetics Corp
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Targeted Genetics Corp, Immunex Corp filed Critical Targeted Genetics Corp
Application granted granted Critical
Publication of ATE190663T1 publication Critical patent/ATE190663T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
AT95908618T 1994-01-28 1995-01-20 Cd69 - transkriptionsregulierende elemente ATE190663T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18843394A 1994-01-28 1994-01-28
PCT/US1995/000837 WO1995020670A1 (en) 1994-01-28 1995-01-20 Cd 69 transcriptional regulatory elements

Publications (1)

Publication Number Publication Date
ATE190663T1 true ATE190663T1 (de) 2000-04-15

Family

ID=22693125

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95908618T ATE190663T1 (de) 1994-01-28 1995-01-20 Cd69 - transkriptionsregulierende elemente

Country Status (8)

Country Link
US (1) US5759805A (de)
EP (1) EP0741791B1 (de)
AT (1) ATE190663T1 (de)
AU (1) AU682253B2 (de)
CA (1) CA2182116C (de)
DE (1) DE69515645T2 (de)
DK (1) DK0741791T3 (de)
WO (1) WO1995020670A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795587A (en) 1995-01-23 1998-08-18 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
US6051429A (en) * 1995-06-07 2000-04-18 Life Technologies, Inc. Peptide-enhanced cationic lipid transfections
US20030069173A1 (en) * 1998-03-16 2003-04-10 Life Technologies, Inc. Peptide-enhanced transfections
DE19545351C1 (de) * 1995-12-05 1997-07-31 Univ Ludwigs Albert Eukaryotische Zellen mit Hybridrezeptor und dadurch steuerbarem Genkonstrukt, Verfahren zu deren Herstellung und Verwendung dieser Zellen in der Gentherapie
ES2296419T3 (es) 1998-11-12 2008-04-16 Invitrogen Corporation Reactivos de transfeccion.
CN106572974B (zh) 2014-07-15 2021-04-23 生命技术公司 用于将分子有效递送到细胞的具有脂质聚集体的组合物和方法
CN104195155A (zh) * 2014-08-05 2014-12-10 浙江大学 一种转基因小鼠动物模型的构建方法
EP3976805A1 (de) 2019-05-27 2022-04-06 Immatics US, Inc. Virale vektoren und ihre verwendung in der adoptiven zelltherapie

Also Published As

Publication number Publication date
WO1995020670A1 (en) 1995-08-03
EP0741791B1 (de) 2000-03-15
AU682253B2 (en) 1997-09-25
AU1686895A (en) 1995-08-15
EP0741791A1 (de) 1996-11-13
CA2182116C (en) 2007-03-20
CA2182116A1 (en) 1995-08-03
DE69515645D1 (de) 2000-04-20
US5759805A (en) 1998-06-02
DE69515645T2 (de) 2000-09-21
DK0741791T3 (da) 2000-06-05

Similar Documents

Publication Publication Date Title
MX9705039A (es) Genes y proteinas de muerte celular programada.
EP1143004A3 (de) Gegen Nematode aktive Bacillus thuringiensis-Mikroben, und Gene kodierend für Nematode-aktive Toxine kloniert von Bacillus thuringiensis-Stämmen
ATE320500T1 (de) Nukleotid-sequenzen zur kontrolle der exprimierung von dns-sequenzen in einem zellulärem wirt
ATE301201T1 (de) Für die gentherapie verwendbare plasmide
DE69534618D1 (de) Verfahren zur herstellung rekombinanter adeno-associated viren (aav) und deren verwendung
BG102612A (en) Complementary adenoviral vector systems and cellular lines
DE69532283D1 (de) EIN PILZ, IN DEM DAS areA-GEN VERÄNDERT IST, UND EIN areA-GEN AUS ASPERGILLUS ORYZAE
NO950534D0 (no) Modufiserte soppceller og fremgangsmåter for fremstilling av rekombinante produkter
DE69326776T2 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
EP0871496A4 (de)
DE69533794D1 (de) Für eine cinnamoyl-coa-reduktase kodierende dna-sequenzen, und ihre verwendung in regulation des lignin-gehalts von pflanzen
PT909315E (pt) Cck-2, um receptor da tirosina cinase
DE69515645T2 (de) Cd69 - transkriptionsregulierende elemente
DK0651784T3 (da) Gærstammer, der udtrykker LDH-genet af mælk og vektorer, som kan anvendes til opnåelse af de nævnte stammer
ATE314481T1 (de) Promotor des transaldolase-genes von k.lactis und dessen verwendung
PT648836E (pt) Transactivador do mhc de classe ii (ciita) e suas utilizacoes
DE69526087D1 (de) Or-1, ein wais-rezeptor der nuklearen rezeptoren familie
FR2693200B1 (fr) Nouveaux polypeptides ayant une activité de récepteur sérotoninergique, acides nucléiques codant pour ces polypeptides et utilisations.
ZA933493B (en) Calcium channel blocking polypeptides from filistata hibernalis.
FI962047A (fi) Endoteliiniä muuntava entsyymi
WO2003080105A3 (fr) Genes regulateurs de l'angiogenese, preparations pharmaceutiques les contenant et leurs applications
DE69531678D1 (de) Rekombinatie viren,ihre herstellung und ihre verwendung in der gentherapie
ATE348109T1 (de) Das gen prv-1 und dessen verwendung
DE69519654T2 (de) htFIIIA Gen
MX9706569A (es) Virus recombinantes que expresan la lecitina-colesterol aciltransferasa y sus usos en terapia genica.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties